临床肿瘤学杂志

• 临床应用 • 上一篇    下一篇

外科手术治疗肝癌合并门静脉癌栓的疗效分析

张奕文1,彭伟雄1,梁 健2   

  1. 1 518000 广东深圳 深圳市光明新区人民医院普外科 2 516000 茂名市人民医院普外科
  • 收稿日期:2012-11-06 修回日期:2012-12-05 出版日期:2013-02-28 发布日期:2013-02-28

Clinical analysis of surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus

ZHANG Yiwen, PENG Weixiong, LIANG Jian   

  1. Department of General Surgery, Guangming New District Peoples Hospital of Shenzhen, Shenzhen 518000,China
  • Received:2012-11-06 Revised:2012-12-05 Online:2013-02-28 Published:2013-02-28

摘要: 目的 探讨肝细胞癌(HCC)合并门静脉癌栓(PVTT)患者行外科手术治疗的疗效。方法 收集1998年1月至2008年12月34例经手术治疗的HCC合并PVTT患者的临床诊治资料并进行回顾性分析。结果 34例HCC合并PVTT患者术后1个月内死亡2例,32例恢复良好。获随访29例(90.6%),中位生存时间为16.2个月,1、2、3、4、5年生存率分别为51.7%、37.9%、24.1%、10.3%和3.4%。其中术后行门静脉及肝动脉双置管灌注化疗者23例,1、2、3、4、5年的生存率分别为57.1%、42.9%、28.6%、14.3%和4.7%,中位生存时间为19.6个月;单纯手术组9例,1、2、3、4、5年的生存率分别为45.0%、22.2%、11.1%、0、0,中位生存时间为13.5个月。两组生存率比较,差异有统计学意义(P<0.05)。结论 肝切除加PVTT摘除术是治疗HCC合并PVTT有效的方法之一,术后门静脉和肝动脉双置管灌注化疗能提高患者远期生存率。

Abstract: Objective To investigate the efficacy of surgical treatment of hepatocellular carcinoma(HCC) with portal vein tumor thrombi(PVTT).Methods From January 1998 to December 2008,the data of 34 patients of hepatocellular carcinoma with PVTT who had undergone operation were analyzed retrospectively. Results There were 2 cases of death within one month after operation,32 patients gained good recovery. Twentynine cases were followed up(90.6%),the median survival time was 16.2 months,the overall 1-,2-,3-,4-,5-year survival rates were 51.7%,37.9%,24.1%,10.3% and 3.4%,respectively. There were 23 patients who recevied portal vein(PV) and hepatic artery catheterizing chemotherapy;the overall 1-,2-,3-,4-,5-year survival rates were 57.1%,42.9%,28.6%,14.3% and 4.7%,respectively.The median survival time was 19.6 months.There were 9 patients with only surgical operation; the overall 1-,2-,3-,4-,5-year survival rates were 45.0%,22.2%,11.1%,0 and 0, respectively. The median survival time was 13.5 months. There were statistical differences between two groups(P<0.05). Conclusion Resection of HCC and removal of tumor thrombus in the portal vein is an effective method for hepatocellular carcinoma with tumor thrombus in the portal vein. Postoperative catheterizing chemotherapy may increase survival rates.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!